Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40:136–54.
Article
CAS
PubMed
Google Scholar
Pafili K, Papanas N, Ziegler D. Neuropathy in diabetes: “one cannot begin it too soon.” Angiology 2018;69:752–754.
Papanas N, Vinik AI, Ziegler D. Neuropathy in prediabetes: does the clock start ticking early? Nat Rev Endocrinol. 2011;7:682–90.
Article
CAS
PubMed
Google Scholar
Bönhof GJ, Herder C, Strom A, Papanas N, Roden M, Ziegler D. Emerging biomarkers, tools, and treatments for diabetic polyneuropathy. Endocr Rev. 2019;40:153–92.
Article
PubMed
Google Scholar
Stirban A, Heinemann L. Skin autofluorescence - a non-invasive measurement for assessing cardiovascular risk and risk of diabetes. Eur Endocrinol. 2014;10:106–10.
Article
PubMed
PubMed Central
Google Scholar
Snelson M, Coughlan MT. Dietary advanced glycation end products: digestion, metabolism and modulation of gut microbial ecology. Nutrients. 2019;11:2.
Google Scholar
Chen XUE, Pyzik R, Yong A, Striker GE. AGE’s in foods and practical ways to reduce them. J Am Diet Assoc. 2013;110:911–6.
Google Scholar
Bos DC, de Ranitz-Greven WL, de Valk HW. Advanced glycation end products, measured as skin autofluorescence and diabetes complications: a systematic review. Diabetes Technol Ther. 2011;13:773–9.
Article
CAS
PubMed
Google Scholar
Van Waateringe RP, Slagter SN, Van Beek AP, van der Klauw MM, van Vliet-Ostaptchouk JV, Graaff R, et al. Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components. Diabetol Metab Syndr. 2017;9:42.
Article
PubMed
PubMed Central
CAS
Google Scholar
Yamagishi S, Matsui T, Nakamura K. Possible involvement of tobacco-derived advanced glycation end products (AGEs) in an increased risk for developing cancers and cardiovascular disease in former smokers. Med Hypotheses. 2008;71:259–61.
Article
CAS
PubMed
Google Scholar
Isami F, West BJ, Nakajima S, Yamagishi SI. Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population. J Int Med Res. 2018;46:1043–51.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gatopoulou A, Papanas N, Maltezos E. Diabetic gastrointestinal autonomic neuropathy: current status and new achievements for everyday clinical practice. Eur J Intern Med. 2012;23:499–505.
Article
CAS
PubMed
Google Scholar
Papanas N, Ziegler D. Risk factors and comorbidities in diabetic neuropathy: an update 2015. Rev Diabet Stud. 2015;12:48–62.
Article
PubMed
PubMed Central
Google Scholar
Vlassara H, Striker GE. Advanced glycation endproducts in diabetes and diabetic complications. Endocrinol Metab Clin N Am. 2013;42:697–719.
Article
Google Scholar
Selvarajah D, Kar D, Khunti K, Davies MJ, Scott AR, Walker J, et al. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol. 2019;7:938–48.
Article
PubMed
Google Scholar
Pafili K, Trypsianis G, Papazoglou D, Maltezos E, Papanas N. Correlation of cardiac autonomic neuropathy with small and large peripheral nerve function in type 2 diabetes mellitus. Diabetes Res Clin Pract. 2019;156:107844.
Article
CAS
PubMed
Google Scholar
Papanas N, Pafili K, Demetriou M, Chatzikosma G, Papachristou S, Papazoglou D. Automated measurement of sural nerve conduction is a useful screening tool for peripheral neuropathy in type 1 diabetes mellitus. Rev Diabet Stud. 2019;15:58–9.
Article
PubMed
PubMed Central
Google Scholar
Papanas N. Diabetic neuropathy collection: progress in diagnosis and screening. Diabetes Ther. 2020;11:761–4.
Article
PubMed
PubMed Central
Google Scholar
Ardeleanu V, Toma A, Pafili K, Papanas N, Motofei I, Diaconu CC, et al. Current pharmacological treatment of painful diabetic neuropathy: a narrative review. Medicina. 2020;56(1).
Smit AJ, Gerrits EG. Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease. Curr Opin Nephrol Hypertens. 2010;19:527–33.
Article
CAS
PubMed
Google Scholar
Fokkens BT, Smit AJ. Skin fluorescence as a clinical tool for non-invasive assessment of advanced glycation and long-term complications of diabetes. Glycoconj J. 2016;33:527–35.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gerrits EG, Lutgers HL, Kleefstra N, Graaff R, Groenier KH, Smit AJ, et al. Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care. 2008;31:517–21.
Article
CAS
PubMed
Google Scholar
Chabroux S, Canouï-Poitrine F, Reffet S, Mills-Joncour G, Morelon E, Colin C, et al. Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy. Diabetes Metab. 2010;36:152–7.
Article
CAS
PubMed
Google Scholar
Sugisawa E, Miura J, Iwamoto Y, Uchigata Y. Skin autofluorescence reflects integration of past long-term glycemic control in patients with type 1 diabetes. Diabetes Care. 2013;36:2339–45.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yoshioka K. Skin autofluorescence is a noninvasive surrogate marker for diabetic microvascular complications and carotid intima-media thickness in Japanese patients with type 2 diabetes: a cross-sectional study. Diabetes Ther. 2018;9:75–85.
Article
CAS
PubMed
Google Scholar
Bentata R, Cougnard-Grégoire A, Delyfer MN, Delcourt C, Blanco L, Pupier E, et al. Skin autofluorescence, renal insufficiency and retinopathy in patients with type 2 diabetes. J Diabetes Complicat. 2017;31:619–23.
Article
Google Scholar
Tanaka K, Tani Y, Asai J, Nemoto F, Kusano Y, Suzuki H, et al. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with type 2 diabetes. Diabet Med. 2012;29:492–500.
Article
CAS
PubMed
Google Scholar
Yasuda M, Shimura M, Kunikata H, Kanazawa H, Yasuda K, Tanaka Y, et al. Relationship of skin autofluorescence to severity of retinopathy in type 2 diabetes. Curr Eye Res. 2015;40:338–45.
Article
CAS
PubMed
Google Scholar
Hirano T, Iesato Y, Toriyama Y, Imai A, Chiba D, Murata T. Correlation between diabetic retinopathy severity and elevated skin autofluorescence as a marker of advanced glycation end-product accumulation in type 2 diabetic patients. J Diabetes Complicat. 2014;28:729–34.
Article
Google Scholar
Noordzij MJ, Mulder DJ, Oomen PH, Brouwer T, Jager J, Castro Cabezas M, et al. Skin autofluorescence and risk of micro- and macrovascular complications in patients with type 2 diabetes mellitus-a multi-Centre study. Diabet Med. 2012;29:1556–61.
Article
CAS
PubMed
Google Scholar
Rajaobelina K, Farges B, Nov S, Maury E, Cephise-Velayoudom FL, Gin H, et al. Skin autofluorescence and peripheral neuropathy four years later in type 1 diabetes. Diabetes Metab Res Rev. 2017;33:e2832.
Article
CAS
Google Scholar
Nagaraj RH, Oya-ito T, Bhat M, Liu B. Dicarbonyl stress and apoptosis of vascular cells: prevention by αB-Crystallin. Ann N Y Acad Sci. 2005;1043:158–65.
Article
CAS
PubMed
Google Scholar
Ejaz S, Chekarova I, Ejaz A, Sohail A, Lim CW. Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy. Diabetes Obes Metab. 2008;10:53–63.
CAS
PubMed
Google Scholar
Meerwaldt R, Links TP, Graaff R, Hoogenberg K, Lefrandt JD, Baynes JW, et al. Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia. 2005;48:1637–44.
Article
CAS
PubMed
Google Scholar
Orchard TJ, Lyons TJ, Cleary PA, Braffett BH, Maynard J, Cowie C, et al. The association of skin intrinsic fluorescence with type 1 diabetes complications in the DCCT/EDIC study. Diabetes Care. 2013;36:3146–53.
Article
CAS
PubMed
PubMed Central
Google Scholar
Osawa S, Katakami N, Sato I, Ninomiya H, Omori K, Yamamoto Y, et al. Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes. J Diabetes Complicat. 2018;32:839–44.
Article
Google Scholar
Wan L, Qin G, Yan W, Sun T. Skin autofluorescence is associated with diabetic peripheral neuropathy in chinese patients with type 2 diabetes: a cross-sectional study. Genet Test Mol Biomarkers. 2019;23:387–92.
Article
PubMed
PubMed Central
Google Scholar
Stirban AO, Bondor CI, Florea B, Veresiu IA, Gavan NA. Skin autofluorescence: correlation with measures of diabetic sensorimotor neuropathy. J Diabetes Complicat. 2018;32:851–6.
Article
Google Scholar
Bierhaus A, Fleming T, Stoyanov S, Leffler A, Babes A, Neacsu C, et al. Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nat Med. 2012;18:926–33.
Article
CAS
PubMed
Google Scholar
Hu H, Han CM, Hu XL, Ye WL, Huang WJ, Smit AJ. Elevated skin autofluorescence is strongly associated with foot ulcers in patients with diabetes: a cross-sectional, observational study of Chinese subjects. J Zhejiang Univ Sci B. 2012;13:372–7.
Article
PubMed
PubMed Central
Google Scholar
Vouillarmet J, Maucort-Boulch D, Michon P, Thivolet C. Advanced glycation end products assessed by skin autofluorescence: a new marker of diabetic foot ulceration. Diabetes Technol Ther. 2013;15:601–5.
Article
CAS
PubMed
Google Scholar
Conway BN, Aroda VR, Maynard JD, Matter N, Fernandez S, Ratner RE, et al. Skin intrinsic fluorescence correlates with autonomic and distal symmetrical polyneuropathy in individuals with type 1 diabetes. Diabetes Care. 2011;34:1000–5.
Article
PubMed
PubMed Central
Google Scholar
Stirban A, Gawlowski T, Roden M. Vascular effects of advanced glycation endproducts: clinical effects and molecular mechanisms. Mol Metab. 2014;3:2212–8778.
Article
CAS
Google Scholar
Stirban A. Noninvasive skin fluorescence spectroscopy for diabetes screening. J Diabetes Sci Technol. 2013;7:1001–4.
Article
PubMed
PubMed Central
Google Scholar
Stirban A. Measurement of lens autofluorescence for diabetes screening. J Diabetes Sci Technol. 2014;8:50–3.
Article
PubMed
PubMed Central
Google Scholar
Ziegler D, Papanas N, Schnell O, Nguyen BDT, Nguyen KT, Kulkantrakorn K, et al. Current concepts in the management of diabetic polyneuropathy. Diabetes Invest. 2020. https://doi.org/10.1111/jdi.13401 Online ahead of print.
Shiferaw WS, Akalu TY, Work Y, Aynalem YA. Prevalence of diabetic peripheral neuropathy in Africa: a systematic review and meta-analysis. BMC Endocr Disord. 2020;20:49.
Article
PubMed
PubMed Central
Google Scholar
Fernando ME, Crowther RG, Cunningham M, Lazzarini PA, Sangla KS, Golledge J. Lower limb biomechanical characteristics of patients with neuropathic diabetic foot ulcers: the diabetes foot ulcer study protocol. BMC Endocr Disord. 2015;15:59.
Article
PubMed
PubMed Central
Google Scholar
Lee CM, Chang CC, Pan MY, Chang CF, Chen MY. Insufficient early detection of peripheral neurovasculopathy and associated factors in rural diabetes residents of Taiwan: a cross-sectional study. BMC Endocr Disord. 2014;14:89.
Article
PubMed
PubMed Central
CAS
Google Scholar
Boulton AJM. The 2017 Banting memorial lecture. The diabetic lower limb - a forty year journey: from clinical observation to clinical science. Diabet Med. 2019;36:1539–49.
Article
PubMed
Google Scholar
Panagoulias GS, Eleftheriadou I, Papanas N, Manes C, Kamenov Z, Tesic D, et al. Dryness of foot skin assessed by the visual indicator test and risk of diabetic foot ulceration: a prospective observational study. Front Endocrinol. 2020;11:625.
Article
Google Scholar